|
Volumn 12, Issue 11, 2013, Pages 1645-1646
|
Ponatinib circumvents all types of imatinib resistance in chronic myelogenous leukemia cell lines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
DASATINIB;
IMATINIB;
NILOTINIB;
PONATINIB;
CANCER PROGNOSIS;
CANCER RESISTANCE;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
EDITORIAL;
HUMAN;
POINT MUTATION;
PROTEIN EXPRESSION;
|
EID: 84878574628
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.24982 Document Type: Editorial |
Times cited : (8)
|
References (8)
|